540 related articles for article (PubMed ID: 21499702)
1. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
[TBL] [Abstract][Full Text] [Related]
2. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
Hanley GE; Brain U; Oberlander TF
Early Hum Dev; 2013 Aug; 89(8):519-24. PubMed ID: 23384962
[TBL] [Abstract][Full Text] [Related]
3. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
[TBL] [Abstract][Full Text] [Related]
4. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
5. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
6. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
Santucci AK; Singer LT; Wisniewski SR; Luther JF; Eng HF; Dills JL; Sit DK; Hanusa BH; Wisner KL
J Clin Psychiatry; 2014 Oct; 75(10):1088-95. PubMed ID: 25373117
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
Lund N; Pedersen LH; Henriksen TB
Arch Pediatr Adolesc Med; 2009 Oct; 163(10):949-54. PubMed ID: 19805715
[TBL] [Abstract][Full Text] [Related]
8. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
[TBL] [Abstract][Full Text] [Related]
9. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
[TBL] [Abstract][Full Text] [Related]
10. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
Smith MV; Sung A; Shah B; Mayes L; Klein DS; Yonkers KA
Early Hum Dev; 2013 Feb; 89(2):81-6. PubMed ID: 22999988
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
[TBL] [Abstract][Full Text] [Related]
12. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
[TBL] [Abstract][Full Text] [Related]
13. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence.
Oberlander TF; Gingrich JA; Ansorge MS
Clin Pharmacol Ther; 2009 Dec; 86(6):672-7. PubMed ID: 19890255
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.
Casper RC; Fleisher BE; Lee-Ancajas JC; Gilles A; Gaylor E; DeBattista A; Hoyme HE
J Pediatr; 2003 Apr; 142(4):402-8. PubMed ID: 12712058
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
Eke AC; Saccone G; Berghella V
BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
[TBL] [Abstract][Full Text] [Related]
16. Does fetal exposure to SSRIs or maternal depression impact infant growth?
Wisner KL; Bogen DL; Sit D; McShea M; Hughes C; Rizzo D; Confer A; Luther J; Eng H; Wisniewski SW
Am J Psychiatry; 2013 May; 170(5):485-93. PubMed ID: 23511234
[TBL] [Abstract][Full Text] [Related]
17. Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study.
van der Veere CN; de Vries NKS; van Braeckel KNJA; Bos AF
Early Hum Dev; 2020 Aug; 147():105075. PubMed ID: 32504880
[TBL] [Abstract][Full Text] [Related]
18. In utero antidepressant exposure and neurodevelopment in preterm infants.
Batton B; Batton E; Weigler K; Aylward G; Batton D
Am J Perinatol; 2013 Apr; 30(4):297-301. PubMed ID: 22893558
[TBL] [Abstract][Full Text] [Related]
19. SSRI antidepressants: altered psychomotor development following exposure in utero?
Prescrire Int; 2013 Feb; 22(135):43-4. PubMed ID: 23444502
[TBL] [Abstract][Full Text] [Related]
20. Prenatal SSRI exposure: Effects on later child development.
Hermansen TK; Melinder A
Child Neuropsychol; 2015; 21(5):543-69. PubMed ID: 25089614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
